10.03
前日終値:
$10.01
開ける:
$9.95
24時間の取引高:
7,418
Relative Volume:
0.27
時価総額:
$76.53M
収益:
-
当期純損益:
$-61.23M
株価収益率:
-0.7419
EPS:
-13.5194
ネットキャッシュフロー:
$22.49M
1週間 パフォーマンス:
+18.56%
1か月 パフォーマンス:
-5.29%
6か月 パフォーマンス:
-44.59%
1年 パフォーマンス:
-22.37%
Assembly Biosciences Inc Stock (ASMB) Company Profile
名前
Assembly Biosciences Inc
セクター
電話
(833) 409-4583
住所
TWO TOWER PLACE, SOUTH SAN FRANCISCO
ASMB を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ASMB
Assembly Biosciences Inc
|
10.03 | 76.53M | 0 | -61.23M | 22.49M | -13.52 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-25 | 開始されました | Guggenheim | Buy |
2024-09-20 | アップグレード | Jefferies | Hold → Buy |
2021-09-13 | 開始されました | H.C. Wainwright | Neutral |
2021-09-02 | ダウングレード | William Blair | Outperform → Mkt Perform |
2021-03-23 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2020-11-06 | ダウングレード | Jefferies | Buy → Hold |
2020-10-19 | 開始されました | Truist | Buy |
2019-10-16 | 開始されました | Mizuho | Buy |
2018-11-19 | 開始されました | Leerink Partners | Outperform |
2018-10-08 | アップグレード | B. Riley FBR | Neutral → Buy |
2018-08-08 | 開始されました | Robert W. Baird | Outperform |
2018-04-13 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
2018-01-05 | 開始されました | B. Riley FBR, Inc. | Neutral |
2017-11-08 | 開始されました | Jefferies | Buy |
2017-05-30 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Assembly Biosciences Inc (ASMB) 最新ニュース
Assembly Biosciences director sells $7,455 in stock - Investing.com Australia
Assembly Biosciences director sells $7,455 in stock By Investing.com - Investing.com South Africa
Assembly Biosciences Presents New Data Highlighting Long-Acting - GuruFocus
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress - The Manila Times
Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround - Yahoo Finance
ASMB stock touches 52-week low at $8.21 amid market challenges - Investing.com
ASMB stock touches 52-week low at $8.21 amid market challenges By Investing.com - Investing.com South Africa
Mastercard Is Taking On the World and Winning - The Globe and Mail
Assembly Biosciences, Inc. (NASDAQ:ASMB) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough - simplywall.st
(ASMB) Investment Report - news.stocktradersdaily.com
Consumer Internet Stocks Q4 Teardown: Remitly (NASDAQ:RELY) Vs The Rest - The Globe and Mail
Assembly Biosciences CEO sells shares worth $3,496 By Investing.com - Investing.com Canada
Assembly Biosciences officer sells $1,772 in stock By Investing.com - Investing.com South Africa
Assembly Biosciences CEO sells shares worth $3,496 - Investing.com
Assembly Biosciences officer sells shares for $1,940 - Investing.com India
Assembly Biosciences officer sells $1,772 in stock - Investing.com India
Five9 (FIVN): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail
ASMB stock touches 52-week low at $10.1 amid market challenges - Investing.com
Q4 Earnings Outperformers: Fastenal (NASDAQ:FAST) And The Rest Of The Maintenance and Repair Distributors Stocks - The Globe and Mail
Assembly Biosciences (ASMB) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Research Analysts Offer Predictions for ASMB Q1 Earnings - Defense World
Guggenheim Initiates Coverage of Assembly Biosciences (ASMB) with Buy Recommendation - MSN
Research Analysts Issue Forecasts for ASMB FY2029 Earnings - Defense World
Assembly Biosciences (NASDAQ:ASMB) Now Covered by Guggenheim - Defense World
Assembly Biosciences Reports 2024 Financial Results and Progress - TipRanks
This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Guggenheim Initiates Assembly Biosciences at Buy With $31 Price Target - MarketScreener
Assembly Biosciences (NASDAQ:ASMB) Lowered to Hold Rating by StockNews.com - Defense World
Assembly Biosciences (NASDAQ:ASMB) Receives “Neutral” Rating from HC Wainwright - Defense World
Assembly Biosciences: 2024 Earnings Surge, Pipeline Promises - AInvest
Assembly Biosciences Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Assembly Biosciences Inc Reports Annual EPS of -$6.69 and Revenue of $28.5 Million, Surpassing Estimates - GuruFocus
3 Reasons LNW is Risky and 1 Stock to Buy Instead - The Globe and Mail
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Update - Defense World
Assembly Biosciences Inc Files For Mixed Shelf Offering Of Up To $250 Million -March 20, 2025 at 05:09 pm EDT - Marketscreener.com
Assembly Biosciences Inc. (ASMB) reports earnings - Quartz
Assembly Biosciences FY Net Income USD 40.177 Million -March 20, 2025 at 04:53 pm EDT - Marketscreener.com
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights - The Manila Times
ASSEMBLY BIOSCIENCES, INC. SEC 10-K Report - TradingView
Assembly Biosciences (ASMB) to Release Earnings on Thursday - Defense World
Assembly Biosciences Insiders Placed Bullish Bets Worth US$679.4k - Yahoo
(ASMB) Proactive Strategies - news.stocktradersdaily.com
ASMB stock touches 52-week low at $10.8 amid market challenges - Investing.com Australia
ASMB stock touches 52-week low at $10.8 amid market challenges By Investing.com - Investing.com South Africa
Is Assembly Biosciences, Inc. (ASMB) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
Assembly Biosciences Inc (ASMB) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):